Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
POTASSIUM ASPARTATE; MAGNESIUM ASPARTATE; HEPTAMINOL HYDROCHLORIDE; SODIUM SELENITE; DISODIC ADENOSINE MONOPHOSPHATE; CYANOCOBALAMIN (VITAMIN B12)
TROY LABORATORIES PTY LTD
sodium selenite(0.5mg/mL)+magnesium aspartate(15mg/mL) + others
PARENTERAL LIQUID/SOLUTION/SUSPENSION
POTASSIUM ASPARTATE AMINO ACID-ASPARTATE Active 10.0 mg/ml; MAGNESIUM ASPARTATE AMINO ACID-ASPARTATE Active 15.0 mg/ml; HEPTAMINOL HYDROCHLORIDE AMINE/AMIDE Active 5.0 mg/ml; SODIUM SELENITE MINERAL-SELENIUM Active 0.5 mg/ml; DISODIC ADENOSINE MONOPHOSPHATE NUCLEOTIDE Active 2.0 mg/ml; CYANOCOBALAMIN (VITAMIN B12) VITAMIN-B12 Active 250.0 ug/ml
100mL
VM - Veterinary Medicine
TROY LABORATORIES
DOG | HORSE | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT
NUTRITION & METABOLISM
AZOTURIA | EXERTIONAL RHABDOMYOLYSIS | TYING-UP
Poison schedule: 6; Withholding period: WHP: NIL; Host/pest details: DOG: [AZOTURIA]; HORSE: [AZOTURIA]; Poison schedule: 6; Withholding period: ; Host/pest details: DOG: [AZOTURIA]; HORSE: [AZOTURIA]; An aid in the control of exertional rhabdomyolysis (ER) in horses and dogs (tying up syndrome in horses).
Registered
2023-07-01
12 53 52 53 51.25 31.5 85 31.5 50.25 12.25 105 211 File Name: 63237_45099_100ML_CARTON_MPL_V2 Dimensions: 53 x 52 x 85mm Scale: A3 = 100% to scale Date: 6 April 2010 ACTIVE CONSTITUENTS: Sodium selenite 0.5 mg/mL Magnesium aspartate 15.0 mg/mL Potassium aspartate 10.0 mg/mL Cyanocobalamin 250 µg/mL Heptaminol hydrochloride 5.0 mg/mL Disodic adenosine monophosphate 2.0 mg/mL ACTIVE CONSTITUENTS: Sodium selenite 0.5 mg/mL Magnesium aspartate 15.0 mg/mL Potassium aspartate 10.0 mg/mL Cyanocobalamin 250 µg/mL Heptaminol hydrochloride 5.0 mg/mL Disodic adenosine monophosphate 2.0 mg/mL 100mL 100mL 100mL Plastic Vial Plastic Vial CD1213 9313754221302 barcode Muscular Stimulant for horses and dogs Muscular Stimulant for horses and dogs Muscular Stimulant for horses and dogs _An aid in the control of Exertional _ _Rhabdomyolysis (ER) in horses and dogs_ _(tying up syndrome in horses)_ _An aid in the control of Exertional _ _Rhabdomyolysis (ER) in horses and dogs_ _(tying up syndrome in horses)_ POISON KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY POISON KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY DIRECTIONS FOR USE Use the contents of this vial within 90 days of initial broaching. Discard the unused contents. DOSAGE AND ADMINISTRATION Administer via intramuscular or subcutaneous injection Treatment 1 injection once every 3 days for 9 to 12 days Prevention 1 injection once a week for 2 to 3 weeks Horses - Adult 20mL Horses - Foals 10 mL Dogs 2 to 5 mL according to size by subcutaneous or intramuscular route If used in performance animals, the regulations of the relevant authorities regarding medication should be observed. MEAT WITHHOLDING PERIOD NIL FIRST AID If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126. If skin contact occurs, remove contaminated clothing and wash skin thoroughly. TROY LABORATORIES PTY. LIMITED 98 LONG ST SMITHFIELD, NSW 2164 W: www.troylab.com.au E: info@troylab.com.au DISPOSAL Dispose of empty container by wrapping with paper and pu Read the complete document
MATERIAL SAFETY DATA SHEET PRODUCT NAME: TROY DYNAJEC INJECTION - MUSCULAR STIMULANT FOR HORSES AND DOGS PAGE: 1 OF 5 THIS REVISION ISSUED: SEPTEMBER, 2011 MATERIAL SAFETY DATA SHEET Issued by: Troy Laboratories Pty Ltd Phone: 02 9677 9000 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769 TEL: (02) 9677 9000 31-35 GLENDENNING ROAD FAX: (02) 9677 9300 GLENDENNING NSW 2761 CHEMICAL NATURE: Blend of ingredients in water solution; presented as an injectable solution. TRADE NAME: TROY DYNAJEC INJECTION - MUSCULAR STIMULANT FOR HORSES AND DOGS APVMA CODE: 63237 PRODUCT USE: An aid in the control of muscular dystrophy in horses and dogs (tying-up syndrome in horses) for use as described on the product label. CREATION DATE: SEPTEMBER, 2011 THIS VERSION ISSUED: SEPTEMBER, 2011 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: R33. Danger of cumulative effects. SAFETY PHRASES: S24/25. Avoid contact with skin and eyes. SUSMP CLASSIFICATION: S6 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : Clear red to dark red liquid. ODOUR: Slight alcohol-like odour. MAJOR HEALTH HAZARDS: danger of cumulative effects. POTENTIAL HEALTH EFFECTS On injection, heptaminol has an adrenalin-like action in horses. 20g heptaminol is equivalent to the action produced by 0.5mg adrenalin. INHALATION: SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects Read the complete document